Lapatinib, Doramapimod with Remdesivir teamed against COVID-19
Souradip Mallick, National Institute of Technology, Rourkela The emergence of SARS-CoV-2 virus has resulted in a worldwide pandemic killed over 1,368,000 people globally (WHO). Currently, effective treatments to inhibit SARS-CoV-2 morbidity and mortality are not available. The pharmacological screen identified several compounds capable of blocking the in vitro replication of two beta-coronaviruses. Among many ones […]